As Vaccines Roll Out, Americans See COVID-19 Testing as Important Partner

- The development and authorization of a COVID-19 vaccine is a critical scientific milestone in our efforts to combat this pandemic. Abbott (NYSE: ABT) released findings today from a survey conducted by The Harris Poll, showing that Americans see testing as an essential partner to these new vaccines. Among the key findings:

  • Importance of Testing as Partner to Vaccine: 82% of Americans say the
    COVID-19 vaccine rollout will be more effective if it works in partnership with testing.
  • Precautionary Measures Support Vaccines: When asked whether a vaccine by itself or a layered strategy would help combat the pandemic and allow us to get back to normal as quickly as possible, 73% of Americans believe a COVID-19 vaccine cannot succeed without other precautionary measures . However, when asked about concerns following approval of a vaccine, many are concerned (very or somewhat) that testing (71%), mask wearing (75%), and social distancing (76%) will decline following vaccine authorization.

"Like the rest of the globe, Americans are anxious to return to normalcy. The authorization of vaccines is an important and tremendous development in our fight against COVID-19," said Andrea Wainer, executive vice president, Rapid and Molecular Diagnostics, Abbott. "Americans agree that we should stay vigilant in other important safety measures, including testing, mask wearing and social distancing. Abbott will remain focused on providing as many tests as possible so people can access them throughout the duration of the pandemic and beyond."

Since the onset of the pandemic, Abbott has launched eight COVID-19 tests for emergency use in the U.S. including lab-based and rapid molecular tests, antibody tests, and a rapid antigen test, which was recently authorized for at-home use with a prescription and certified virtual guide. Abbott has delivered more than 300 million COVID-19 tests worldwide.

As we await widespread access to the vaccine, Americans agree that testing remains essential to curbing the pandemic right now.

  • Role of Testing in Interim: 86% of Americans say testing will play a significant (very or somewhat) role in combatting the pandemic while we wait for vaccines to be made widely available.
  • Importance of Detecting Infectiousness: 66% of Americans say rapid antigen COVID-19 testing is a critical tool to combat the pandemic because of its ability to detect the most infectious people.

As initial doses of the vaccines are prioritized for populations like frontline healthcare workers and seniors in long-term care facilities, rapid antigen tests are as important as ever to identify infectious individuals and slow the spread of the virus among those who have not been vaccinated.

"With cases rising and critical winter months ahead, we must continue to use every preventative measure available to us to slow the spread of the virus," said Mary Rodgers , PhD., principal scientist, Diagnostics, Abbott. "It's important that diagnostic companies, public health leaders, policymakers and citizens continue to advocate for the role of vaccines and testing in partnership with other important safety measures like mask wearing, social distancing and hand washing."

This survey was conducted online within the United States by The Harris Poll on behalf of Abbott from December 10 December 14, 2020 , among 2,064 U.S. adults ages 18 and older.

For a summary of the data, please click here .

About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com , on LinkedIn at www.linkedin.com/company/abbott-/ , on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.

Cision View original content: https://www.prnewswire.com/news-releases/as-vaccines-roll-out-americans-see-covid-19-testing-as-important-partner-301197237.html

SOURCE Abbott

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Seegnal (TSXV:SEGN)

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in AI-enhanced prescription intelligence, today announced real-world clinical results demonstrating how medication governance may reduce fall-risk drivers in older adults -- a significant clinical and financial challenge... Keep Reading...
Cardiologist wearing virtual reality glasses.

Top 3 Medical Device ETFs for Investors in 2026

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone, 30 new devices were approved by the US Food and Drug Administration (FDA).Wearable medical devices and the use of artificial intelligence in medical... Keep Reading...
Scientists working in a modern medical research laboratory.

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...

Interactive Chart

Latest Press Releases

Related News